| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 10/30/2013 | EP2654800A1 Therapeutic strategies to treat cns pathology in mucopolysaccharidoses |
| 10/30/2013 | EP2332582B1 ACE2 activation for treatment of heart, lung and kidney disease and hypertension |
| 10/30/2013 | CN103380113A Amine-containing transfection reagents and methods for making and using same |
| 10/30/2013 | CN103379921A Treatment of spinal cord injury and traumatic brain injury using amnion derived adherent cells |
| 10/30/2013 | CN103374577A Sheep ISG (immune serum globulin) 15 recombinant protein as well as coding gene and application thereof |
| 10/30/2013 | CN103374573A Hepatoma cell aptamer sequence and application thereof |
| 10/30/2013 | CN103374552A PHF 8 (Plant Homedomain Finger Protein 8) protein fragment as well as prokaryotic expression and purification method and antibody thereof |
| 10/30/2013 | CN103374128A Amphiphilic triblock copolymer, polymer nano-carrier preparation and preparation methods |
| 10/30/2013 | CN103374072A Preparation of anti-Mac-2BP humanized antibody |
| 10/30/2013 | CN103374071A Preparation of anti-DERLIN-1 humanized antibody |
| 10/30/2013 | CN103374068A Preparation method and application of novel monoclonal antibody |
| 10/30/2013 | CN103372218A microRNA related to autoimmune disease and application thereof |
| 10/30/2013 | CN103372217A Polymer nano carrier preparation as well as preparation method and application thereof |
| 10/30/2013 | CN103372207A DNA vaccine resisting multi-type avian influenza virus and composition thereof |
| 10/30/2013 | CN103371277A Stable food containing gold nanoparticles |
| 10/30/2013 | CN102757483B Recombinant adenovirus for expressing porcine teschovirus type 8 VP1 protein and application thereof |
| 10/30/2013 | CN102559761B Method for regulating development of embryonic liver cells by SNX7 gene and application of SNX7 gene |
| 10/30/2013 | CN101550185B Tumor-related gene or protein and application thereof |
| 10/29/2013 | US8569474 Double stranded constructs comprising one or more short strands hybridized to a longer strand |
| 10/29/2013 | US8569471 Stem cell beacon |
| 10/29/2013 | US8569258 Low density lipoprotein receptor-mediated siRNA delivery |
| 10/29/2013 | US8569255 Post-exposure therapy of influenza A infections |
| 10/29/2013 | US8569253 Methods and compositions for gene inactivation |
| 10/29/2013 | US8569251 Use of microwave irradiation for delivery of macromolecules |
| 10/29/2013 | US8569065 Compositions and methods for the delivery of biologically active RNAs |
| 10/29/2013 | US8568969 RBP4 in insulin sensitivity/resistance, diabetes, and obesity |
| 10/29/2013 | US8568742 Methods and compositions involving immunostimulatory oligodeoxynucleotides |
| 10/29/2013 | US8568709 Thymidylate kinase fusions and uses thereof |
| 10/29/2013 | US8568707 Light emitting microorganisms and cells for diagnosis and therapy of tumors |
| 10/29/2013 | CA2546619C Il-23 and its receptor; related reagents and methods |
| 10/29/2013 | CA2477406C Dna vaccine against proliferating endothelial cells and methods of use thereof |
| 10/29/2013 | CA2466128C Antibodies to cd40 |
| 10/29/2013 | CA2435672C Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses |
| 10/29/2013 | CA2382120C Single-stranded oligodeoxynucleotide mutational vectors |
| 10/29/2013 | CA2375467C Antisense therapy for hormone-regulated tumors |
| 10/29/2013 | CA2371794C Human antibiotic proteins |
| 10/24/2013 | WO2013159108A2 Oligomeric compounds comprising bicyclic nucleotides and uses thereof |
| 10/24/2013 | WO2013159103A1 Programming and reprogramming of cells |
| 10/24/2013 | WO2013159051A1 Morpholino-mediated increase in soluble flt-1 expression results in decreased ocular and tumor neovascularization |
| 10/24/2013 | WO2013158879A1 Composition and methods for highly efficient gene transfer using aav capsid variants |
| 10/24/2013 | WO2013158782A2 Methods and compositions for treating cardiac arrhythmias |
| 10/24/2013 | WO2013158717A2 Compositions comprising an internalizing nucleic acid molecule, and their methods of use |
| 10/24/2013 | WO2013158290A1 Methods and compositions for manipulating the immune system |
| 10/24/2013 | WO2013158256A2 Immunomodulation by anti-cd3 immunotoxins to treat cancers not uniformly bearing surface cd3 |
| 10/24/2013 | WO2013157010A1 Methods and compositions for rnai-based cancer treatment |
| 10/24/2013 | WO2013156920A1 Klotho variant polypeptides and uses thereof in therapy |
| 10/24/2013 | WO2013156625A1 Tfeb gene therapy of alpha-1-antitrypsin deficiency |
| 10/24/2013 | WO2013155980A1 Auto-immune disease-related microrna and use thereof |
| 10/24/2013 | WO2012092373A3 In vivo polynucleotide delivery conjugates having enzyme sensitive linkages |
| 10/24/2013 | WO2002079390A9 $i(pesudomonas) avr and hop proteins, their encoding nucleic acids, and use thereof |
| 10/24/2013 | WO2002079385A9 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 10/24/2013 | US20130281685 iRNA AGENTS WITH BIOCLEAVABLE TETHERS |
| 10/24/2013 | US20130281515 Cationic bis-urea compounds as effective antimicrobial agents |
| 10/24/2013 | US20130281382 Stable lipid-comprising drug delivery complexes and methods for their production |
| 10/24/2013 | US20130280735 Gene Expression Control DNA Element and Associated Protein |
| 10/24/2013 | US20130280299 Viral vectors and their use in therapeutic methods |
| 10/24/2013 | US20130280217 Methods for Use of a Specific Anti-Angiogenic Adenoviral Agent |
| 10/24/2013 | US20130280216 Methods for Use of a Specific Anti-Angiogenic Adenoviral Agent |
| 10/23/2013 | EP2653561A1 Ultraconserved regions encoding ncRNAs |
| 10/23/2013 | EP2653542A1 Methods and compositions related to mutant kunitz domain I of TFPI-2 |
| 10/23/2013 | EP2652506A2 The use anti-cxcl16 and anti-cxcr6 antibodies for the treatment or detecting cancer |
| 10/23/2013 | EP2651452A1 Treatment of spinal cord injury and traumatic brain injury using amnion derived adherent cells |
| 10/23/2013 | EP2651451A1 Treatment of spinal cord injury and traumatic brain injury using placental stem cells |
| 10/23/2013 | CN103370416A Modified single-strand polynucleotide |
| 10/23/2013 | CN103370415A HBV treatment |
| 10/23/2013 | CN103361428A Application of miRNA-132 (micro-ribonucleic acid) compound to preparation of marker for diagnosing chronic pain and medicament for treating chronic pain |
| 10/23/2013 | CN103361427A Application of miRNA-219 (micro-ribonucleic acid) compound to preparation of marker for diagnosing chronic pain and medicament for treating chronic pain |
| 10/23/2013 | CN103361424A MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors |
| 10/23/2013 | CN103361379A Construction, screening and application of shRNAs expression vector of lung cancer targeted CHRNA5 gene |
| 10/23/2013 | CN103361364A Eimeria tenella eIF3d gene and application thereof |
| 10/23/2013 | CN103361351A ShRNA of human RUNX2 gene, and recombinant interference vector and application thereof |
| 10/23/2013 | CN103361349A Application of BRSK2SR2 in preparation of medicines for inhibiting pancreatic cancer |
| 10/23/2013 | CN103361347A Micro RNA (Ribonucleic Acid) aiming at angiogenin 2 |
| 10/23/2013 | CN103361343A Application of BRSK2SR1 in preparation of medicines for inhibiting pancreatic cancer |
| 10/23/2013 | CN103361328A Mediated integration HIV-1 (Human Immunodeficiency Virus-1) provirus gene knockout zinc finger nuclease as well as preparation method and application thereof |
| 10/23/2013 | CN103360590A Preparation method of methoxy polyethylene glycol-bi-fatty acryl phosphatidyl ethanolamine |
| 10/23/2013 | CN103360477A Modified hepatitis C virus (HCV) Type 4 envelope E2 protein and application thereof |
| 10/23/2013 | CN103360475A Modified hepatitis C virus (HCV) Type 5 envelope E2 protein and application thereof |
| 10/23/2013 | CN103360474A Modified hepatitis C virus (HCV) Type 3a envelope E2 protein and application thereof |
| 10/23/2013 | CN103360473A Modified hepatitis C virus (HCV) Type 6 envelope E2 protein and application thereof |
| 10/23/2013 | CN103360466A Composition of tumour-associated peptides and related anti-cancer vaccine |
| 10/23/2013 | CN103359706A Preparation method and application of cationized magnetic carbon nano-tubes |
| 10/23/2013 | CN103357025A Application of BRSK2 in preparation of medicines for inhibiting pancreatic cancer |
| 10/23/2013 | CN103357024A Liver cancer suicide gene therapy medicine based on aminated silicon dioxide nanoparticle-CD/TK (cytosine deaminase-thymidine kinase) fused gene compound |
| 10/23/2013 | CN103357020A Method for preparing protein-based chitosan nanoparticles and application of chitosan nanoparticles serving as nucleic acid drug carriers |
| 10/23/2013 | CN103357009A Application of Hemokinin-1 in preparation of vaccine adjuvant |
| 10/23/2013 | CN103356996A Treatment of acute coronary syndrome with GLP-1 |
| 10/23/2013 | CN102719432B Double-stranded asymmetric small nucleic-acid-interference-molecule asiRNA inhibiting tumour apoptosis suppressor specifically and application thereof |
| 10/23/2013 | CN102703447B Oligonucleotide with breast cancer treatment effect |
| 10/23/2013 | CN102516395B Polypeptide carrier used for improving targeting ability and transfection efficiency of medicine/gene, and purpose thereof |
| 10/23/2013 | CN102443063B Anti-TNFalpha humanized Fab, humanized antibody and its application |
| 10/23/2013 | CN102416203B RNA interference blood vessel stent coating material with local antiplatelet effect and local anticoagulation blood vessel stent prepared therefrom |
| 10/23/2013 | CN102178959B siRNA for inhibiting growth of pulmonary metastasis tumor and oligonucleotide composition and application thereof |
| 10/22/2013 | US8563529 RNAi therapeutic for treatment of hepatitis C infection |
| 10/22/2013 | US8563528 Antisense oligomers targeting PCSK9 |
| 10/22/2013 | US8563527 Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same |
| 10/22/2013 | US8563519 Methods of activating or inhibiting G protein coupled receptors (GPCRs) |
| 10/22/2013 | US8563313 Macrophage cell-lines for propagation of porcine reproductive and respiratory syndrome virus |
| 10/22/2013 | US8562977 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 10/22/2013 | US8562966 End-modified poly(beta-amino esters) and uses thereof |